{"text": ["Drug", "Pricing", "Woes", "Linger", "on", "Repealing", "Drug", "Rebate", "Proposal"], "created_at": "2019-07-12 18:12:06"}
{"text": ["Drug", "Pricing", "Woes", "Linger", "on", "Repealing", "Drug", "Rebate", "Proposal"], "created_at": "2019-07-12 18:12:06"}
{"text": ["S&P", "500", "Movers:", "ILMN,", "JBHT"], "created_at": "2019-07-12 16:09:20"}
{"text": ["S&P", "500", "Movers:", "ILMN,", "JBHT"], "created_at": "2019-07-12 16:09:20"}
{"text": ["Drug", "Pricing", "Woes", "Linger", "on", "Repealing", "Drug", "Rebate", "Proposal"], "created_at": "2019-07-12 15:35:03"}
{"text": ["Health", "Care", "stocks", "help", "lead", "Wall", "Street", "rally"], "created_at": "2019-07-12 14:23:21"}
{"text": ["Novartis,", "Amgen", "Scrap", "Pivotal", "Study", "Of", "Alzheimer's", "Prevention", "Drug"], "created_at": "2019-07-12 14:19:16"}
{"text": ["Lilly's", "OVERCOME", "Observational", "Study", "Reveals", "Inconsistent", "and", "Sub-Optimal", "Treatment", "Landscape", "for", "Migraine"], "created_at": "2019-07-12 12:00:00"}
{"text": ["AHS", "2019:", "Post-Hoc", "Analyses", "of", "Phase", "3", "Pivotal", "Studies", "of", "Emgality\u00ae", "(galcanezumab-gnlm)", "Show", "Improvements", "in", "Daily", "Functioning", "and", "Reductions", "in", "Disability", "in", "Patients", "with", "Chronic", "and", "Episodic", "Migraine"], "created_at": "2019-07-12 10:45:00"}
